919 related articles for article (PubMed ID: 19481294)
1. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
[TBL] [Abstract][Full Text] [Related]
2. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
[TBL] [Abstract][Full Text] [Related]
4. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
5. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
6. Mycosis fungoides palmaris et plantaris--an unusual variant of cutaneous T-cell lymphoma.
Topf S; Lüftl M; Neisius U; Brabletz T; Simon M; Schuler G; Schultz ES
Eur J Dermatol; 2006; 16(1):84-6. PubMed ID: 16436350
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of primary cutaneous lymphomas in Tehran, Iran (1998-2004).
Manuchehri HM; Rakhshan M
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):758-60. PubMed ID: 16836523
[No Abstract] [Full Text] [Related]
8. Mycosis fungoides--a review of the management of 28 patients and of the recent literature.
Lenane P; Powell FC; O'Keane C; Dervan P; O'Sullivan D; Bourke E; O'Loughlin S
Int J Dermatol; 2007 Jan; 46(1):19-26. PubMed ID: 17214715
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome.
Bi MY; Curry JL; Christiano AM; Hordinsky MK; Norris DA; Price VH; Duvic M
J Am Acad Dermatol; 2011 Jan; 64(1):53-63. PubMed ID: 21036417
[TBL] [Abstract][Full Text] [Related]
10. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
11. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis of primary cutaneous lymphomas].
Grange F; Bagot M
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides.
Väkevä L; Sarna S; Vaalasti A; Pukkala E; Kariniemi AL; Ranki A
Acta Derm Venereol; 2005; 85(4):318-23. PubMed ID: 16191852
[TBL] [Abstract][Full Text] [Related]
15. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
16. Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation.
Kamarashev J; Theler B; Dummer R; Burg G
Int J Dermatol; 2007 Sep; 46(9):930-5. PubMed ID: 17822495
[TBL] [Abstract][Full Text] [Related]
17. Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US Cutaneous Lymphoma Consortium.
Kadin ME; Hughey LC; Wood GS
J Am Acad Dermatol; 2014 Feb; 70(2):374-6. PubMed ID: 24438952
[No Abstract] [Full Text] [Related]
18. [Item 164--Malignant lymphomas: cutaneous lymphomas].
CEDEF
Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A164-6. PubMed ID: 23176840
[No Abstract] [Full Text] [Related]
19. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
20. [Hypopigmented mycosis fungoides in children: a clinicopathological study of 6 cases].
Wang T; Liu YH; Zheng HY; Sun QN; Jin HZ; Li F; Fang K; Yan Y
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(46):3287-90. PubMed ID: 21223789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]